Ronald M Sobecks MD

PubMed

• Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704.
  Mohamed L Sorror, Wael Saber, Brent Logan, Nancy Geller, Anna Bellach
  Blood Advances. 2025-07-08
• Dose to circulating blood in intensity-modulated total body irradiation, total marrow irradiation, and total marrow and lymphoid irradiation.
  Bingqi Guo, Sheen Cherian, Erin S Murphy, Craig S Sauter, Ronald M Sobecks
  Medical Physics. 2025-06-08
• Impact of Obesity on GVHD in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Hematologic Malignancies.
  Valentina Ardila, Hong Li, Claudio Brunstein, Matt Kalaycio, Ronald Sobecks
  Transplantation and Cellular Therapy. 2025-03-01

Journal Articles

• Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation  
  Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
• Neutropenic Fever During Peripheral Blood Progenitor Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Increased Apheresis Collection Days  
  Mat Kalaycio, Robert Dean, Jack Khouri, Brad Pohlman, Aleksandr Lazaryan, Edward Copelan, Steven Andresen, Ronald Sobecks, Hien Liu, Journal of Clinical Apheresis

Abstracts/Posters

• Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-Azacytidine
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Flurabine Improves Transplant Outcomes in Older MDS Patients
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and My...
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation
  Ronald Sobecks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018